Mutational spectrum in the neurofibromatosis type 2 gene in sporadic and familial schwannomas

Human Genetics

Volumn 98, Issue 2, 1996, Pages 189-193

  Bradley Welling, D ^a   Guida, Marco ^a   Goll, Frederick ^a   Pearl, Dennis K ^a   Glasscock, Michael E ^b   Pappas, Dennis G ^b   Linthicum, Fred H ^c   Rogers, David ^a   Prior, Thomas W ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b Otology Group   (United States)

^c HOUSE EAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HETERODUPLEX;

ARTICLE; DNA SEQUENCE; GENE FREQUENCY; GENE MUTATION; GENETIC SCREENING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MISSENSE MUTATION; NEURILEMOMA; NEUROFIBROMATOSIS; PHENOTYPE; PRIORITY JOURNAL;

CODON; CPG ISLANDS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENES, NEUROFIBROMATOSIS 2; HUMANS; MUTATION; NEURILEMMOMA; NEUROFIBROMATOSIS 2; POLYMERASE CHAIN REACTION;

EID: 8944256090     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390050188     Document Type: Article

References (23)

1. Bourn D, Evans G, Mason S, Tekes S, Trueman L, Strachan T (1995) Eleven novel mutations in the NF2 tumour suppressor gene. Hum Genet 95 :572-574
2. Cotton RGH (1993) Current methods of mutation detection. Mutat Res 285:125-144
3. Evans DGR, Hudson SM, Donnai D, Neary W, Blair W, Teare D, Newton V, Strachan T, Ramsden R, Harris R (1992) A genetic study of type-2 neurofibromatosis in the United Kingdom. I. Pevalence, mutation rate, fitness and confirmation of maternal transmission effect on severity. J Med Genet 29:841-846
4. Forsthoefel KF, Papp AC, Snyder PJ, Prior TW (1992) Optimization of DNA extraction from formalin-fixed tissue and its clinical application in Duchenne muscular dystrophy. Am J Clin Pathol 98:98-104
5. Haase VH, Trofatter JA, MacCollin M, Tarttelin E, Gusella JF, Ramesh V (1994) The murine NF2 homologue encodes a highly conserved merlin protein with alternative forms. Hum Mol Genet 3:407-11
6. Heim RA, Kam-Morgan LNW, Binnie CG, Corns DD, Cayouette MC, Farber RA, Aylsworth AS, Silverman LM, Luce MC (1995) Distribution of 13 truncating mutations in the neurofibromatosis 1 gene. Hum Mol Genet 4:975-981
7. Irving RM, Moffat DA, Hardy DO, Barton DE, Xuereb JH, Maher ER (1994) Somatic NF2 gene mutations in familial and non-familial vestibular schwannomas. Hum Mol Genet 3:347-350
8. Jacoby LB, MacCollin M, Louis DN, Mohoney T, Rubio M-P, Pulaski K, Trofalter JA, Kley N, Seizinger B, Ramesh V, Gusella JF (1994) Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 3:413-419
9. MacCollin M, Ramesh V, Jacoby LB, Louis N, Rubio MP, Pulaski K, Trofatter JA, Short MP, Bove C, Eldridge R, Parry DM, Gusella JF (1994) Mutational analysis of patients with neurofibromatosis 2. Am J Hum Genet 55 :314-320
10. Martuza RL, Eldridge R (1988) Neurofibromatosis 2. N Engl J Med 318:684-688
11. Merel P, Hoang-Xuan K, Sanson M, Bijlsma E, Rouleau G, Laurent-Puig P, Pulst S, Baser M, Lenoir G, Sterkers JM, Philippon J, Resche F, Mautner VF, Fischer G, Hulsebos T, Aurias A, Delattre O, Thomas G (1995a) Screening for germ-line mutations in the NF2 gene. Genes Chromosom Cancer 12:117-127
12. Merel P, Hoang-Xuan K, Sanson M, Moreau-Aubry A, Bijlsma EK, Lazaro C, Moisan JP, Resche F, Nishisho I, Estivill X, Delattre JY, Poisson M, Theillet C, Hulsebos T, Delattre O, Thomas G ( 1995b) Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas. Genes Chromosom Cancer 13:1211-1216
13. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
14. Prior TW, Papp AC, Snyder PJ, Sedra MS, Western LS, Bartolo C, Mendell JR (1994) Heteroduplex analysis of the dystrophin gene: application to point mutation and carrier detection. Am J Med Genet 50:68-73
15. Roest PAM, Roberts RG, Sugino S, Ommen GJB van, Dunnen JT den (1993) Protein truncation test for rapid detection of translation-terminating mutations. Hum Mol Genet 2:1719-1721
16. Rouleau GA, Merel P, Lutchman M, Sanson M, Zueman J, Marineau C, Hoang-Xuan K, Demezuk S, Desmaze C, Plougastel B, Pulst SM, Lenoir G, Bijlsma E, Fashold R, Dumanski J, de Jong P, Parry D, Eldrige R, Aurias A, Delattre O, Thomas G (1993) Alteration in a new gene encoding a putative membrane-organising protein causes neurofibromatosis type 2. Nature 363:515-521
17. Sainz J, Huynh DP, Figueroa K, Ragge NK, Baser ME, Pulst SM (1994) Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum Mol Genet 3:885-991
18. Sainz J, Figueroa K, Baser ME, Mautner V-F, Pulst SM (1995) High frequency of nonsense mutations in the NF2 gene caused by C to T transitions in five CGA condons. Hum Mol Genet 4 :137-139
19. Seizinger BR, Martuza RL, Gusella JF (1986) Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma. Nature 322:644-647
20. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, Haase VH, Ambrose CM, Munroe D, Bove C, Haines JL, Martuza RL, MacDonald ME, Seizinger BR, Short MP, Buckler AJ, Gusella JF (1993) A novel moesin-, ezrin-. radxin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72:791-800
21. Twist EC, Ruttledge MH, Rousseau M, Sanson M, Papi L, Merel P, Delattre O, Thomas G, Rouleau GA (1994) The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum Mol Genet 3:147-151
22. Wolff RK, Frazer KA, Jackler RK, Lanser MJ, Pitts LH, Cox DR (1992) Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors. Am J Hum Genet 51:478-485
23. Youssoufian H, Kazazian HH, Phillips DO, Aronis S, Tsiftis G, Brown VA, Antonarakis SE (1986) Recurrent mutations in haemophilia A give evidence for CpG mutation hotspots. Nature 324:380-382